Organoid biobanks as a new tool for pre-clinical validation of candidate drug efficacy and safety.
Int J Physiol Pathophysiol Pharmacol
; 13(1): 17-21, 2021.
Article
en En
| MEDLINE
| ID: mdl-33815668
ABSTRACT
The growing need for personalized medicine for cancer patients has enhanced and optimized the production of living tumor organoids that have become optimal preclinical models for the discovery and screening of anticancer drugs. The systematic collection and storage of tumor organoids through the establishment of dedicated biobanks will represent a fundamental tool for cancer research and clinical trials.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
Int J Physiol Pathophysiol Pharmacol
Año:
2021
Tipo del documento:
Article
País de afiliación:
Italia